Arbutus Biopharma
ABUSArbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.It is headquartered in Vancouver, British Columbia and has research facilities in Warminste …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Arbutus Biopharma
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 2/4/2025 | Sell | $3.3 | $37,206 |
| 2/4/2025 | Sell | $3.3 | $78,103 |
| 2/4/2025 | Sell | $3.3 | $63,519 |
| 2/4/2025 | Sell | $3.3 | $72,827 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)